Clinical Trial Update: An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors [Phase 2]

View source ↗

Summary

An open-label Phase II study evaluating the combination of nivolumab and celecoxib in patients with advanced metastatic solid tumors (described as 'Cold' tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• Celecoxib (Celecoxib)
• nivolumab (nivolumab)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Metastatic Cancer | Phase 2 | Status: UNKNOWN